C
Novo Nordisk A/S NVO
$54.56 $0.260.48% NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 4.03B 4.10B 4.03B 4.02B 2.89B
Total Depreciation and Amortization 638.57M 539.99M 11.58M 316.82M 293.92M
Total Amortization of Deferred Charges -- -- 36.44M -- --
Total Other Non-Cash Items 810.61M 1.15B -2.18B 3.78B 2.68B
Change in Net Operating Assets 723.30M -2.32B -140.20M -1.66B 1.42B
Cash from Operations 6.20B 3.47B 1.76B 6.46B 7.29B
Capital Expenditure -2.23B -1.89B -2.30B -1.79B -1.51B
Sale of Property, Plant, and Equipment -- -- -142.90K 147.40K --
Cash Acquisitions -- -- -11.65B 0.00 -96.39M
Divestitures -- -- -- -- --
Other Investing Activities 62.82M 952.03M 911.93M -1.29B -1.38B
Cash from Investing -2.17B -941.31M -13.04B -3.08B -2.99B
Total Debt Issued 45.24B 27.36B 44.76B 119.00M 34.51B
Total Debt Repaid -64.86B -12.03B -433.00M -532.00M -5.05B
Issuance of Common Stock -- -- -- -- --
Repurchase of Common Stock 0.00 -1.39B -7.49B -2.41B -7.45B
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -4.98B 0.00 -2.30B 0.00
Other Financing Activities -26.78B 26.78B -- -- -5.33B
Cash from Financing -7.03B 768.93M 5.26B -2.71B 2.41B
Foreign Exchange rate Adjustments -123.21M -12.13M 102.47M -51.28M 6.06M
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -3.12B 3.28B -5.91B 618.46M 6.71B